tradingkey.logo

Inotiv Inc

NOTV
0.418USD
+0.028+7.26%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
14.37MValor de mercado
PerdaP/L TTM

Mais detalhes de Inotiv Inc Empresa

Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Informações de Inotiv Inc

Código da empresaNOTV
Nome da EmpresaInotiv Inc
Data de listagemNov 25, 1997
CEOLeasure (Robert W)
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 25
Endereço2701 Kent Ave
CidadeWEST LAFAYETTE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal47906-1382
Telefone13174634527
Sitehttps://www.inotiv.com/
Código da empresaNOTV
Data de listagemNov 25, 1997
CEOLeasure (Robert W)

Executivos da empresa Inotiv Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
694.19K
-14125.00%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
378.73K
-22048.00%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+25000.00%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
104.93K
+27500.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
76.89K
+27500.00%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
19.00K
-36000.00%
Mr. R. Matthew Neff
Mr. R. Matthew Neff
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert W. Leasure, Jr.
Mr. Robert W. Leasure, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Beth A. Taylor
Ms. Beth A. Taylor
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Mr. David Landman
Mr. David Landman
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
694.19K
-14125.00%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
378.73K
-22048.00%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+25000.00%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
104.93K
+27500.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
76.89K
+27500.00%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
19.00K
-36000.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
447.98M
87.32%
Netherlands
35.48M
6.92%
Other
29.56M
5.76%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: qua, 4 de fev
Atualizado em: qua, 4 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
4.04%
Leasure (Robert Jr.)
3.55%
Balyasny Asset Management LP
2.87%
Sagartz (John E)
2.02%
GSA Capital Partners LLP
1.48%
Outro
86.05%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
4.04%
Leasure (Robert Jr.)
3.55%
Balyasny Asset Management LP
2.87%
Sagartz (John E)
2.02%
GSA Capital Partners LLP
1.48%
Outro
86.05%
Tipos de investidores
Investidores
Proporção
Investment Advisor
9.93%
Individual Investor
9.65%
Hedge Fund
6.87%
Investment Advisor/Hedge Fund
4.67%
Corporation
3.66%
Research Firm
2.33%
Venture Capital
0.33%
Bank and Trust
0.14%
Private Equity
0.06%
Outro
62.35%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
168
8.26M
24.01%
-3.92M
2025Q3
173
8.82M
25.69%
-3.41M
2025Q2
195
12.88M
37.49%
-4.07M
2025Q1
224
12.80M
37.26%
-4.48M
2024Q4
233
12.65M
38.89%
+1.31M
2024Q3
250
7.31M
26.57%
-8.16M
2024Q2
259
7.59M
28.13%
-9.62M
2024Q1
274
9.86M
38.07%
-7.14M
2023Q4
278
8.23M
31.98%
-10.32M
2023Q3
287
9.98M
38.79%
-9.73M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
1.40M
4.09%
+20.89K
+1.51%
Sep 30, 2025
Leasure (Robert Jr.)
1.24M
3.61%
+429.73K
+52.90%
Mar 14, 2025
Balyasny Asset Management LP
985.74K
2.87%
-668.91K
-40.43%
Sep 30, 2025
Sagartz (John E)
708.32K
2.06%
+30.00K
+4.42%
Mar 14, 2025
GSA Capital Partners LLP
234.52K
0.68%
+234.52K
--
Sep 30, 2025
UBS Financial Services, Inc.
314.55K
0.92%
+36.34K
+13.06%
Sep 30, 2025
Hardy (Adrian)
400.78K
1.17%
+25.00K
+6.65%
Mar 14, 2025
Renaissance Technologies LLC
359.76K
1.05%
-38.19K
-9.60%
Sep 30, 2025
Massar Capital Management, LP
350.00K
1.02%
--
--
Sep 30, 2025
Vantage Point Financial, LLC.
336.55K
0.98%
--
--
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
Avantis US Small Cap Value ETF
0%
Avantis US Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proporção0.01%
Dimensional US Core Equity 1 ETF
Proporção0%
DFA Dimensional US Core Equity Market ETF
Proporção0%
Avantis US Small Cap Value ETF
Proporção0%
Avantis US Equity ETF
Proporção0%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0%
Avantis US Small Cap Equity ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI